On Dec. 8, 2020, Moderna announced the Swiss Federal Government had increased its confirmed order commitment from 4.5 million to 7.5 million doses of Modernaﾒs vaccine candidate against COVID-19, mRNA-1273. Swiss vaccine supply will be sourced from Modernaﾒs European production capacity with its strategic manufacturing partner Lonza of Switzerland, and ROVI of Spain for fill-finish services.